Philips Respironics is recalling approximately 454,868 Trilogy Evo platform ventilators, including the Trilogy Evo, Trilogy Evo O2, Trilogy EV300, and Trilogy Evo Universal models. The recall was initiated because using non-pneumatic nebulizers with these devices can cause the patient to receive a different amount of air (tidal volume) than what the ventilator is set to provide. This issue affects devices running software version 1.05.15.00 and was reported across worldwide distributions, including over 113,000 units of each model variant.
If there is a discrepancy between the set and received tidal volume, patients may receive insufficient oxygen or too much pressure, which can lead to respiratory distress or lung injury. This risk is specifically present when using non-pneumatic nebulizers with the affected software version.
Recall #: Z-1614-2026; Quantity: 113,717 units; Continuous home-use ventilator device.
Recall #: Z-1615-2026; Quantity: 113,717 units; Continuous home-use ventilator device.
Recall #: Z-1616-2026; Quantity: 113,717 units; Continuous home-use ventilator device.
Recall #: Z-1617-2026; Quantity: 113,717 units; Continuous home-use ventilator device.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.